Chronic Limb Threatening Ischemia Clinical Trials

18 recruitingLast updated: June 18, 2026

There are 18 actively recruiting chronic limb threatening ischemia clinical trials across 16 countries. Studies span Not Applicable, Phase 2. Top locations include New York, New York, United States, Graz, Austria, Charlotte, North Carolina, United States. Updated daily from ClinicalTrials.gov.


Chronic Limb Threatening Ischemia Trials at a Glance

18 actively recruiting trials for chronic limb threatening ischemia are listed on ClinicalTrialsFinder across 6 cities in 16 countries. The largest study group is Not Applicable with 11 trials, with the heaviest enrollment activity in New York, Graz, and Charlotte. Lead sponsors running chronic limb threatening ischemia studies include Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology, Cardiovascular and Interventional Radiological Society of Europe, and Aplagon Oy.

Browse chronic limb threatening ischemia trials by phase

Treatments under study

About Chronic Limb Threatening Ischemia Clinical Trials

Looking for clinical trials for Chronic Limb Threatening Ischemia? There are currently 18 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Chronic Limb Threatening Ischemia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Chronic Limb Threatening Ischemia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 118 of 18 trials

Recruiting
Not Applicable

Intravascular Ultrasound for Peripheral Artery Disease Revascularization

Chronic Limb Threatening IschemiaPeripheral Arterial Disease(PAD)Restenosis+2 more
Hamilton Health Sciences Corporation772 enrolled2 locationsNCT06979284
Recruiting

Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study

Chronic Limb Threatening Ischemia
Cardiovascular and Interventional Radiological Society of Europe400 enrolled39 locationsNCT06149650
Recruiting
Not Applicable

PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

Peripheral Arterial DiseaseChronic Limb Threatening IschemiaCritical Limb Ischemia
LimFlow, Inc.100 enrolled30 locationsNCT05313165
Recruiting
Phase 2

Safety of Antithrombotic Heparin Proteoglycan Mimetic APAC in Peripheral Arterial Occlusive Disease and Chronic Limb-threatening Ischemia

Peripheral arterial occlusive diseaseChronic Limb Threatening Ischemia
Aplagon Oy42 enrolled3 locationsNCT07352800
Recruiting

Durg Coated Balloon Angioplasty in Infrapopliteal Lesions

Chronic Limb Threatening IschemiaPeripheral Artery DiseaseArteriosclerosis
Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology1,000 enrolled10 locationsNCT05620095
Recruiting

Symptomatic and Systemic Atherosclerotic Plaque Activity in Patients With Peripheral Arterial Disease Using Novel Imaging

Peripheral Arterial DiseaseChronic Limb Threatening Ischemia
University of Edinburgh100 enrolled1 locationNCT07472049
Recruiting
Not Applicable

Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease

Chronic Limb Threatening Ischemia
R3 Vascular Inc.300 enrolled3 locationsNCT06071429
Recruiting
Not Applicable

Transverse Tibial Transport for Chronic Limb-Threatening Ischemia (CLTI)

Chronic Limb Threatening Ischemia
University Hospitals Cleveland Medical Center10 enrolled1 locationNCT07175129
Recruiting
Not Applicable

Chronic Wounds and Blood Circulation Detection

AgingWalking, DifficultyChronic Limb Threatening Ischemia+1 more
National Health Research Institutes, Taiwan425 enrolled1 locationNCT07330635
Recruiting
Not Applicable

Pressure Wire Guidance for Infrapopliteal Artery Interventions

Chronic Limb Threatening Ischemia
Yonsei University100 enrolled1 locationNCT06879561
Recruiting

Peripheral Bypass Trial for Completion Control

Chronic Limb Threatening Ischemia
Medistim ASA450 enrolled1 locationNCT06264843
Recruiting
Not Applicable

Revascularization of Single Vesrus Multiple Infrapopliteal Vessels in Chronic Limb Threatening Ischemia

Chronic Limb Threatening IschemiaInfrapopliteal Arterial Occlusive Disease
Sohag University40 enrolled1 locationNCT07068789
Recruiting
Not Applicable

AcoArt Litos PCB Below-the-knee Global Trial

Chronic Limb Threatening Ischemia
Acotec Scientific Co., Ltd288 enrolled10 locationsNCT06330493
Recruiting
Not Applicable

The ROAMM-EHR Study

Peripheral Arterial DiseaseChronic Limb Threatening Ischemia
University of Florida50 enrolled1 locationNCT06263322
Recruiting
Not Applicable

Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease

Diabetes MellitusChronic Limb Threatening IschemiaPeripheral Artery Disease
Nationwide Children's Hospital192 enrolled1 locationNCT03622359
Recruiting

Angioplasty With Shockwave IVL Catheter System in Femoropopliteal Lesions

Chronic Limb Threatening IschemiaPeripheral Artery Disease (PAD)
Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology130 enrolled1 locationNCT06713850
Recruiting

Multimodal Noninvasive Assessment of Peripheral Circulation in Chronic Limb-threatening Ischemia

Chronic Limb Threatening Ischemia
Tampere University150 enrolled1 locationNCT05786001
Recruiting
Not Applicable

Thermovision-controlled Lumbar Sympathetic Blockade in Chronic Limb-threatening Ischemia Treatment

Chronic Limb Threatening Ischemia
EPC Education s.r.o.60 enrolled1 locationNCT06111599